Skip to main content
SVBI logo

SVBI — Investor Relations & Filings

Ticker · 1786 ISIN · TW0001786002 TW Manufacturing
Open in API
Filings indexed 1,687 across all filing types
Latest filing 2021-06-10 Director's Dealing
Country TW Taiwan
Listing TW 1786

About SVBI

www.scivision.com.tw

SciVision Biotech Inc. is a specialized developer and manufacturer of advanced medical devices, focusing on the research and production of hyaluronic acid (HA) products. The company leverages its proprietary Crosslinked Hyaluronic Acid Platform (CHAP) technology to create high-performance solutions across multiple medical disciplines. Its core product portfolio includes subcutaneous fillers for facial aesthetics, intra-articular injections for orthopedic joint care, anti-adhesion gels for surgical applications, and vesical instillation solutions for urological treatments. By integrating specialized R&D capabilities with precision manufacturing, SciVision Biotech provides medical-grade HA applications designed to improve patient outcomes in aesthetics and therapeutic recovery. The company is committed to scientific innovation and the expansion of its patented technology to meet diverse clinical needs in the global healthcare market.

Recent filings

Filing Released Lang Actions
110年05月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document contains detailed tables listing shareholdings of company insiders, including directors, managers, and their related parties. It shows changes in shareholdings, types of shares held, and other related data. This type of document is typical of a Director's Dealing report, which discloses personal share transactions by company directors and executives. There is no indication of financial statements, earnings data, or meeting materials. The document is not an announcement of a report but the actual disclosure of insider shareholdings and transactions. Therefore, the appropriate classification is Director's Dealing (DIRS).
2021-06-10 Chinese
110年05月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tabular data about shareholdings of company insiders, including directors and senior management, with specific numbers of shares held, pledged shares, and related parties' holdings. It is a disclosure of insider shareholdings and changes, typical of a Director's Dealing or insider shareholding notification. The document is relatively short (2475 characters) and focuses on insider shareholdings rather than financial results or management changes. There is no indication of a meeting, voting results, or financial report. The content matches the definition of a Major Shareholding Notification (MRQ) or Director's Dealing (DIRS). Since it reports insider holdings and pledges, it aligns best with Director's Dealing (DIRS).
2021-06-10 Chinese
110年5月營業收入
Regulatory Filings Classification · 95% confidence The document is a brief financial summary showing monthly and cumulative net operating revenue figures for a company, with percentage changes and explanations for revenue changes. It is very short (789 characters) and does not contain detailed financial statements or comprehensive analysis. It appears to be a regulatory disclosure or a brief financial update rather than a full report. There is no indication that this is an earnings release (which typically highlights quarterly results), nor a full annual or interim report. The document is more consistent with a Regulatory Filing (RNS) as it provides a regulatory-required revenue summary without detailed financial data or management discussion.
2021-06-07 Chinese
110年5月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, 科妍, reporting on the status of fund loans and endorsement guarantees for the current and previous month, with zero balances and no guarantees. It contains tabular data but no detailed financial statements or analysis. The length is very short (601 characters), and it is a regulatory disclosure of financial status rather than a full report or announcement of a report. It does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is a regulatory filing providing compliance information about financial guarantees and loans, which fits best under Regulatory Filings (RNS).
2021-06-07 Chinese
公告本公司透明質酸一針及三針關節腔注射劑產品取得 印度醫療器材進口許可證
Regulatory Filings Classification · 95% confidence The document is a short announcement (833 characters) from a company disclosing that its product has obtained an import permit for medical devices in India. It includes details about the product and market potential but does not contain any financial statements, management discussion, or regulatory filings related to financial performance. It is not a report, transcript, or detailed presentation but a regulatory announcement about a product approval. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2021-05-27 Chinese
110年05月僑外投資持股
Major Shareholding Notification Classification · 95% confidence The document is a statistical table showing the shareholding situation of overseas and mainland China investors, including changes before and after a shareholders' meeting. It includes details such as stock codes, shareholding numbers, and dates related to the shareholders' meeting. The document length is short (1053 characters) and it primarily reports shareholding data related to a shareholders' meeting. There is no indication of a full report, financial statements, or detailed analysis. This type of document fits best under Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels or shareholding statistics related to shareholder meetings.
2021-05-24 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.